Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Replimune Group, Inc. (NASDAQ: REPL) resulting from ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. A visit to the chiropractor can provide many health benefits.

Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.

Replimune (REPL) stock plummeted on Tuesday after the biotechnology company received a Complete Response Letter (CRL) from ...

Replimune Group (NASDAQ:REPL – Get Free Report) ‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Thursday, Benzinga reports ...

The Ratings Game Nike’s stock is headed for a ‘swoosh’-shaped recovery after years of pain, analyst says Nike’s latest quarterly results were ‘rough’ but likely marked a bottom as the ...

Nike (NYSE: NKE) provided an update to investors in late June, indicating a recovery was forthcoming. *Stock prices used were the afternoon prices of June 25, 2025. The video was published on June ...

QuantumScape stock surged 75% this week following the company’s announcement of a breakthrough in manufacturing. The recent advancement with the Cobra separator signifies more than just a ...

UnitedHealth Group shares are sliding today following negative industry news from rival insurer Centene. Centene was forced to pull its full-year guidance due to troubling data. The company is ...

The recent robotaxi launch has altered the narrative surrounding the stock, and Tesla may reveal another event that could prove a positive catalyst for the company and the stock. Here's the lowdown.